Regulation of Mammalian Meiotic Decision by Glutamine Transporter Slc38a2
National Institute of General Medical SciencesDescription
Eukaryotes undergo two primary types of cell division: mitosis and meiosis. Somatic cells rely on mitosis to generate genetically identical daughter cells, while germline cells possess the unique ability to transition from mitosis to meiosis, producing haploid daughter cells with distinct genetic characteristics through meiotic recombination and segregation. Despite the conservation of meiotic genes and chromosome structures across yeasts to mammals, the signals initiating meiosis differ. Yeasts respond to nutrient restriction, which inactivates TOR1/cAMP-dependent protein kinase A (PKA) signaling. On the other hand, mammals require retinoic acid (RA), a chordate morphogen, to activate Stra8 (stimulated by retinoic acid gene 8) for meiosis. We propose a hypothesis that aims to reconcile this evolutionary divergence: nutrient restriction, as a conserved signal, drives meiosis from yeasts to mammals. Specifically, our previous study revealed that mammalian meiosis-initiating cells are influenced by an in vivo autophagy-inducing factor. Subsequent research demonstrated that nutrient restriction, a powerful inducer of autophagy and yeast meiosis as mentioned earlier, induces meiosis in cultured mouse male germline stem cells (mGSCs). Interestingly, our recent transcriptomic study sheds light on how mammalian germ cells "starve themselves" for meiosis in vivo. It shows that during meiotic initiation, nutrient transporter expression is repressed, and this process is facilitated by retinoic acid (RA) and Stra8 through H3K27 deacetylation. Together, these findings suggest that, unlike yeast meiosis, which passively depends on environmental nutrient conditions, mammalian germ cells actively withdraw their nutrient transporters to restrict nutrient uptake and initiate meiosis. In this study, we will: 1) Investigate the role of mTORC1/PKA as signaling hubs connecting Slc38a2 with meiotic initiation; 2) Characterize the metabolic mechanisms that Slc38a2 controls meiotic initiation. Project Number: 1R01GM157716-01 | Fiscal Year: 2025 | NIH Institute/Center: National Institute of General Medical Sciences (NIGMS) | Principal Investigator: Ning Wang | Institution: UNIVERSITY OF KANSAS MEDICAL CENTER, KANSAS CITY, KS | Award Amount: $952,117 | Activity Code: R01 | Study Section: Cellular, Molecular and Integrative Reproduction Study Section[CMIR] View on NIH RePORTER: https://reporter.nih.gov/project-details/11040225
Interested in this grant?
Start a free 7-day trial to get match scores, save grants, and build your application with AI.
Grant Details
$952,117 - $952,117
Not specified
KANSAS CITY, KS
View the application link
Start a free 7-day trial to open the original listing and funder website, save this grant, and track its deadline. Cancel anytime.
Start free trialWant to see how well this grant matches your organization?
Get Your Match Score